Dr. Byun joined Aisling in 2020 and serves as an Associate. Prior to Aisling, Dr. Byun was a Vice President in the Healthcare Investment Banking Group at Morgan Stanley where he advised clients in the biotechnology industry. Prior to Morgan Stanley, Dr. Byun was an Associate in the Healthcare M&A Group at Lazard. During his time at Morgan Stanley and Lazard, he helped raise over $3.2 billion in equity capital and was involved in approximately $50 billion of M&A transactions.
Dr. Byun currently serves as a board observer of Monte Rosa Therapeutics. Dr. Byun is a board member of the University of Virginia Benefactor Society, an associate board member of Rising Ground, and a member of Off the Record, an affiliation of The Foreign Policy Association.
Dr. Byun received his M.B.A from the University of Chicago Booth School of Business, M.D. from Tulane University School of Medicine, where he was a DeBakey Scholar, and B.S. in Biochemistry with Specialization in Molecular Genetics and B.A. in Biology from the University of Virginia.
Ryuk is attending / has attended:
Sign up now to stay up-to-date with all our events, news, deals and more!